Excess Mortality With Alzheimer Disease and Related Dementias as an Underlying or Contributing Cause During the COVID-19 Pandemic in the US

Abstract

ImportanceAdults with Alzheimer disease and related dementias (ADRD) are particularly vulnerable to the direct and indirect effects of the COVID-19 pandemic. Deaths associated with ADRD increased substantially in pandemic year 1. It is unclear whether mortality associated with ADRD declined when better prevention strategies, testing, and vaccines became widely available in year 2.ObjectiveTo compare pandemic-era excess deaths associated with ADRD between year 1 and year 2 overall and by age, sex, race and ethnicity, and place of death.Design, Setting, and ParticipantsThis time series analysis used all death certificates of US decedents 65 years and older with ADRD as an underlying or contributing cause of death from January 2014 through February 2022.ExposureCOVID-19 pandemic era.Main Outcomes and MeasuresPandemic-era excess deaths associated with ADRD were defined as the difference between deaths with ADRD as an underlying or contributing cause observed from March 2020 to February 2021 (year 1) and March 2021 to February 2022 (year 2) compared with expected deaths during this period. Expected deaths were estimated using data from January 2014 to February 2020 fitted with autoregressive integrated moving average models.ResultsOverall, 2 334 101 death certificates were analyzed. A total of 94 688 (95% prediction interval [PI], 84 192-104 890) pandemic-era excess deaths with ADRD were estimated in year 1 and 21 586 (95% PI, 10 631-32 450) in year 2. Declines in ADRD-related deaths in year 2 were substantial for every age, sex, and racial and ethnic group evaluated. Pandemic-era ADRD-related excess deaths declined among nursing home/long-term care residents (from 34 259 [95% PI, 25 819-42 677] in year 1 to −22 050 [95% PI, −30 765 to −13 273] in year 2), but excess deaths at home remained high (from 34 487 [95% PI, 32 815-36 142] in year 1 to 28 804 [95% PI, 27 067-30 571] in year 2).Conclusions and RelevanceThis study found that large increases in mortality with ADRD as an underlying or contributing cause of death occurred in COVID-19 pandemic year 1 but were largely mitigated in pandemic year 2. The most pronounced declines were observed for deaths in nursing home/long-term care settings. Conversely, excess deaths at home and in medical facilities remained high in year 2.

The impact of COVID-19 on deaths from dementia and Alzheimer’s disease in Chile: an analysis of panel data for 16 regions, 2017–2022

“…Regarding the place of death in the pre-pandemic period, 67.44% of deaths (dementia and AD) occurred at home, increasing to 77.84% of deaths at home during the pandemic period. Our findings align with similar trends reported by Chen et al., 14 who observed a significant increase in deaths that occurred at home among older people with AD and dementia, compared to those that occurred in nursing homes. This change can be attributed to the unique circumstances of the COVID-19 pandemic, where due to fear of transmission, many home care clients canceled in-person visits.…”

“…Their results indicated a large increase in mortality in the first year of the pandemic, with excess deaths in long-stay health homes; and a decrease in mortality in the second year of the pandemic, with excess deaths at home and medical centres. 14 …”

Outcomes of COVID-19-Associated Hospitalizations in Geriatric Patients with Dementia in the United States: A Propensity Score Matched Analysis

“…The adoption of telemedicine emerged as a preferred approach by which to minimize hospital visits, and potentially fewer patients required hospitalization as a result. Additionally, initial data indicate that vaccinations play a pivotal role in reducing the severity of disease manifestations, further limiting the necessity for hospital admissions [ 27 ].…”

2024 Alzheimer's disease facts and figures

“…Data for more recent years are still being compiled, but one study found that deaths due to all dementias, including Alzheimer's, decreased between March 2021 and February 2022, in particular among residents of nursing homes and long‐term care facilities. 417 …”